Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse. (2018)

First Author: Bonsall D
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/idr.s156581

PubMed Identifier: 30127629

Publication URI: http://europepmc.org/abstract/MED/30127629

Type: Journal Article/Review

Volume: 11

Parent Publication: Infection and drug resistance

ISSN: 1178-6973